NanoViricides (NNVC) Earnings Date & Reports

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NNVC is expected to report earnings to fall 13.64% to -9 cents per share on December 02

NanoViricides NNVC Stock Earnings Reports

Q3'26

Est.

$-0.09

Q2'26

Missed

by $0.01

Q1'26

Missed

by $0.02

Q4'25

Beat

by $0.06

Q2'25

Beat

by $0.07

The last earnings report on September 02 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 54.24K shares outstanding, the current market capitalization sits at 39.06M.

View a ticker or compare two or three

NNVC

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for NNVC